The pharmaceutical industry expects it will take 12 to 18 months to roll out a coronavirus vaccine, executives said Thursday, as they jointly pledged to make it available worldwide based on need.
Bureaucracy could be slashed to speed up the process — but the time needed for safety testing could not be compromised, industry chiefs and the International Federation of Pharmaceutical Manufacturers and Associations told a virtual press conference hosted in Geneva.
We’re confident technology will arrest this disease,” said IFPMA president David Ricks, the chairman of Eli Lilly and Company. The global death toll has risen to over 9,000 with more than 217,000 confirmed infections, according to an AFP tally based on official sources.
When you think about how many people we will want to vaccinate once we have a vaccine around the world, we’re talking billions, and that’s a huge challenge,” said David Loew, the executive vice president of Sanofi Pasteur. “We need to ensure the safety.
It’s going to take 12 to 18 months until you have a registered vaccine on the market. The regulatory authorities are cutting red tape, and that’s the way we can accelerate getting to the market quicker.
Venkayya added that some, if not most of the testing programmes being run, would fail to produce a viable vaccine. However, the value of running multiple trials simultaneously was that some will succeed and get across the finish line.